Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • niel
    Junior Member
    • Feb 2014
    • 4

    #1

    edgeR issue:RNA seq

    I am facing an error at the step Trended Dispersion, although no error during Common dispersion estimation.

    rownames(design) <- colnames (d)
    > z<- estimateGLMCommonDisp(d , design)
    v<- estimateGLMTrendedDisp(d , design)
    Error in t(y) + prior.count.scaled : non-conformable arrays

    Please suggest what could be the reason, and what would be the way out.
  • niel
    Junior Member
    • Feb 2014
    • 4

    #2
    do I have to edit aveLogCPM.default, if yes, then How?

    Comment

    • bruce01
      Senior Member
      • Mar 2011
      • 160

      #3
      I think

      v<- estimateGLMTrendedDisp(d , design)

      should be

      v<- estimateGLMTrendedDisp(z , design)

      ie you have to run CommonDisp on 'd', and then run TrendedDisp on the output of that.

      Comment

      • niel
        Junior Member
        • Feb 2014
        • 4

        #4
        Ok.. yah.. Thanks. I was making some silly input mistake in some earlier step too. That step, including your suggession make it work properly. But strangely, all 20 top tags are showing Downregulation in disease. That has made me a bit sceptical. I am doing double check now.

        Thanks

        Comment

        • bruce01
          Senior Member
          • Mar 2011
          • 160

          #5
          Good that it works; to check your top 20 tags I suggest you look at FPKM/RPKM or raw counts to make sure the 'direction' of regulation is correct. EdgeR gives "-logFC" for the first condition you provide IIRC. This can be confusing, and I still double check all results against FPKMs.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Working...